Fundz

MicroTransponder has raised $65 million in a Series F financing round to enhance Vivistim adoption for chronic stroke recovery. The funding round was led by US Venture Partners along with several other notable investors.

PUBLIC · MOBIMar 12, 2025

Amount Raised

$65 Million

Round Type

Series F

AustinHealthcare

Investors

Gilde HealthcareLongitude CapitalUS Venture PartnersOsage University PartnersAction Potential Venture CapitalGPG VenturesThe Vertical GroupExceller Hunt Ventures

Description

MicroTransponder®, Inc. has announced a $65 million Series F financing round aimed at transforming stroke recovery care with its FDA-approved Vivistim® Paired VNS™ System. This funding will help enhance the adoption of their innovative solution for chronic stroke recovery. The round was led by US Venture Partners and included participation from both current and new investors

Quick answer

Mobia Medical, Inc. raised $65 Million in a Series F round, dated March 12, 2025. Investors: Gilde Healthcare, Longitude Capital, US Venture Partners, Osage University Partners, Action Potential Venture Capital, GPG Ventures, The Vertical Group and Exceller Hunt Ventures. Mobia Medical, Inc. is based in Austin, Texas, United States.

How much did Mobia Medical, Inc. raise?
Mobia Medical, Inc. raised $65 Million in a Series F round on March 12, 2025.
Who invested in Mobia Medical, Inc?
Gilde Healthcare, Longitude Capital, US Venture Partners, Osage University Partners, Action Potential Venture Capital, GPG Ventures, The Vertical Group and Exceller Hunt Ventures are named as investors in this round.
What does Mobia Medical, Inc. do?
MicroTransponder®, Inc. is a privately held, global medical device company based in Austin, Texas, committed to developing research-based neuroscience solutions.
Where is Mobia Medical, Inc. based and how big is it?
Mobia Medical, Inc. is based in Austin, Texas, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Mobia Medical, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $20M (Series B) on February 21, 2025.
  • Hummingbird Healthcare raised $19M on February 14, 2025.
  • Cristcot raised $10M on April 25, 2025.
  • Araceli Biosciences raised $11M (Seed) on April 24, 2025.
  • Ascellus raised $454K (Seed) on April 24, 2025.
  • Apnimed raised $16M on April 23, 2025.

Who to call at Mobia Medical, Inc., and when

A new round usually means Mobia Medical, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mobia Medical, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mobia Medical, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mobia Medical, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mobia Medical, Inc.

Location

2802 Flintrock Trace, Suite 226

Austin, Texas, United States

About

MicroTransponder®, Inc. is a privately held, global medical device company based in Austin, Texas, committed to developing research-based neuroscience solutions. The company focuses on restoring dignity and enhancing daily living for people suffering from neurological conditions that impair sensory and motor function. MicroTransponder's FDA-approved Vivistim® Paired VNS™ System is a first-of-its-kind, clinically proven medical technology that generates two to three times more improvement in upper limb function than rehabilitation alone for stroke survivors after six weeks of in-clinic therapy. For more information, visit Vivistim.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mobia Medical, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mobia Medical, Inc.'s next move

See what Strategic adds

Mobia Medical, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.